Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma.
Laverdiere C, Kolb EA, Supko JG, Gorlick R, Meyers PA, Maki RG, Wexler L, Demetri GD, Healey JH, Huvos AG, Goorin AM, Bagatell R, Ruiz-Casado A, Guzman C, Jimeno J, Harmon D.
Laverdiere C, et al. Among authors: huvos ag.
Cancer. 2003 Aug 15;98(4):832-40. doi: 10.1002/cncr.11563.
Cancer. 2003.
PMID: 12910529
Free article.
Clinical Trial.